{
    "clinical_study": {
        "@rank": "9900", 
        "acronym": "HyperVOPTICA", 
        "arm_group": {
            "arm_group_label": "Monocular Adaptive Optics Visual Simulator (AOVIS-I)", 
            "arm_group_type": "Other"
        }, 
        "brief_summary": {
            "textblock": "The primary purpose of the protocol is to evaluate the adaptive optics visual simulator to\n      measure optical aberrations in hyperopic eyes.\n\n      The study hypotheses are the:\n\n        -  Ability to measure optical aberrations in hypermetropia.\n\n        -  Knowledge of optical aberrations of the eye hyperopic.\n\n        -  To adapt therapeutic management in optical aberrations measured."
        }, 
        "brief_title": "Feasibility of Measurement of Optical Aberrations in Hyperopia by Using an Adaptive Optics Visual Simulator (AOVIS-I)", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Hyperopic Patients", 
        "condition_browse": {
            "mesh_term": "Hyperopia"
        }, 
        "detailed_description": {
            "textblock": "The procedure is guided by the custom made software and its graphical user interface. The\n      interface has been designed to be user-friendly, being very similar to the software usually\n      managed by the clinicians in their daily professional practice. The complete procedure in\n      one patient takes less than 5 minutes and is completely non-invasive. The optical\n      measurements only involve the use of low power infrared laser and the visual testing is as\n      simple for the patients as watching television and making responses."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  hyperopic patients\n\n          -  to be able to understand an information and give a consent\n\n          -  patients over 18\n\n          -  affiliated to medical insurance\n\n        Exclusion Criteria:\n\n          -  patients under 18\n\n          -  pregnant women or nursing mothers\n\n          -  ocular infection\n\n          -  keratitis\n\n          -  restless patients\n\n          -  ocular surgery 90 days before inclusion"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01884805", 
            "org_study_id": "12 483 03", 
            "secondary_id": "HAO"
        }, 
        "intervention": {
            "arm_group_label": "Monocular Adaptive Optics Visual Simulator (AOVIS-I)", 
            "description": "The procedure is guided by the custom made software and its graphical user interface. The interface has been designed to be user-friendly, being very similar to the software usually managed by the clinicians in their daily professional practice. The complete procedure in one patient takes less than 5 minutes and is completely non-invasive. The optical measurements only involve the use of low power infrared laser and the visual testing is as simple for the patients as watching television and making responses.", 
            "intervention_name": "Monocular Adaptive Optics Visual Simulator (AOVIS-I)", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Adaptive Optics Visual Simulator", 
            "Wavefront aberrometer", 
            "Optical Aberrations", 
            "Hyperopia"
        ], 
        "lastchanged_date": "June 21, 2013", 
        "location": {
            "contact": {
                "email": "malecaze.fr@chu-toulouse.fr", 
                "last_name": "Fran\u00e7ois MALECAZE, PHD", 
                "phone": "05 61 77 77 52", 
                "phone_ext": "33"
            }, 
            "contact_backup": {
                "email": "fournie.p@chu-toulouse.fr", 
                "last_name": "Pierre FOURNIE, PHD", 
                "phone": "05 61 77 77 52", 
                "phone_ext": "33"
            }, 
            "facility": {
                "address": {
                    "city": "Toulouse", 
                    "country": "France", 
                    "state": "Midi-Pyrenees", 
                    "zip": "31059"
                }, 
                "name": "University Hospital, Toulouse"
            }, 
            "investigator": [
                {
                    "last_name": "Fran\u00e7ois MALECAZE, PHD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Pierre FOURNIE, PHD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "C\u00e9line GUILLAUD, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Feasibility of Measurement of Optical Aberrations in Hyperopia by Using an Adaptive Optics Visual Simulator (AOVIS-I)", 
        "overall_contact": {
            "email": "malecaze.fr@chu-toulouse.fr", 
            "last_name": "Fran\u00e7ois MALECAZE, PHD", 
            "phone": "05 61 77 77 52", 
            "phone_ext": "33"
        }, 
        "overall_contact_backup": {
            "email": "fournie.p@chu-toulouse.fr", 
            "last_name": "Pierre FOURNIE, PHD", 
            "phone": "05 61 77 77 52", 
            "phone_ext": "33"
        }, 
        "overall_official": {
            "last_name": "Fran\u00e7ois MALECAZE, PHD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Feasibility of Measurement of optical aberrations in hyperopia by using an Adaptive Optics Visual Simulator AOVIS-I. Outcome measure is assessed during a consultation", 
            "measure": "Measurement of optical aberrations", 
            "safety_issue": "No", 
            "time_frame": "1 day (Participants will be followed for the duration of ophtalmology consultation)"
        }, 
        "reference": [
            {
                "PMID": "12361172", 
                "citation": "Fern\u00e1ndez EJ, Manzanera S, Piers P, Artal P. Adaptive optics visual simulator. J Refract Surg. 2002 Sep-Oct;18(5):S634-8."
            }, 
            {
                "PMID": "15557473", 
                "citation": "Piers PA, Fernandez EJ, Manzanera S, Norrby S, Artal P. Adaptive optics simulation of intraocular lenses with modified spherical aberration. Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4601-10."
            }, 
            {
                "PMID": "17889766", 
                "citation": "Piers PA, Manzanera S, Prieto PM, Gorceix N, Artal P. Use of adaptive optics to determine the optimal ocular spherical aberration. J Cataract Refract Surg. 2007 Oct;33(10):1721-6."
            }, 
            {
                "PMID": "19550905", 
                "citation": "Manzanera S, Prieto PM, Ayala DB, Lindacher JM, Artal P. Liquid crystal Adaptive Optics Visual Simulator: Application to testing and design of ophthalmic optical elements. Opt Express. 2007 Nov 26;15(24):16177-88."
            }, 
            {
                "PMID": "18552387", 
                "citation": "Villegas EA, Alc\u00f3n E, Artal P. Optical quality of the eye in subjects with normal and excellent visual acuity. Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4688-96. doi: 10.1167/iovs.08-2316. Epub 2008 Jun 14."
            }, 
            {
                "PMID": "19550501", 
                "citation": "Fern\u00e1ndez EJ, Prieto PM, Artal P. Wave-aberration control with a liquid crystal on silicon (LCOS) spatial phase modulator. Opt Express. 2009 Jun 22;17(13):11013-25."
            }, 
            {
                "PMID": "19724513", 
                "citation": "Fern\u00e1ndez EJ, Prieto PM, Artal P. Binocular adaptive optics visual simulator. Opt Lett. 2009 Sep 1;34(17):2628-30. doi: 10.1364/OL.34.002628."
            }, 
            {
                "PMID": "19757958", 
                "citation": "P\u00e9rez GM, Manzanera S, Artal P. Impact of scattering and spherical aberration in contrast sensitivity. J Vis. 2009 Mar 25;9(3):19.1-10. doi: 10.1167/9.3.19."
            }, 
            {
                "PMID": "20090810", 
                "citation": "Bueno JM, Acosta E, Schwarz C, Artal P. Wavefront measurements of phase plates combining a point-diffraction interferometer and a Hartmann-Shack sensor. Appl Opt. 2010 Jan 20;49(3):450-6. doi: 10.1364/AO.49.000450."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01884805"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Evaluate the reproducibility of the measures obtained in hyperopic eyes. Outcome measure is assessed during a consultation", 
                "measure": "Reproductibility of the measures", 
                "safety_issue": "No", 
                "time_frame": "1 day (Participants will be followed for the duration of ophtalmology consultation)"
            }, 
            {
                "description": "Expression of optical aberrations in numerical measures. Outcome measure is assessed during a consultation", 
                "measure": "Quantitative measurement of optical aberrations", 
                "safety_issue": "No", 
                "time_frame": "1 day (Participants will be followed for the duration of ophtalmology consultation)"
            }
        ], 
        "source": "University Hospital, Toulouse", 
        "sponsors": {
            "collaborator": {
                "agency": "Centre de R\u00e9f\u00e9rence National du K\u00e9ratoc\u00f4ne (CRNK)", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University Hospital, Toulouse", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}